SC-110237

N/A

Report date: 2025/06/11 10:52:13
NME

Base Information

Drug NameSC-110237
Drug Alias NameFlt3 inhibitor (Shanghai De Novo Pharmatech)fms-like tyrosine kinase 3 inhibitor (Shanghai De Novo Pharmatech)SC-110219SC-110237
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai De Novo Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai De Novo Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A